Evidence map›Paper›PMID 36985801›Full record

ArticleMolecules (Basel, Switzerland)2023

Bioactive C21 Steroidal Glycosides from

Xiaoyi Feng, Jianchun Li, Hongmei Li, Xuanqin Chen, Dan Liu, Rongtao Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoyi FengCenter for Pharmaceutical Sciences and Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Jianchun LiCenter for Pharmaceutical Sciences and Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Hongmei LiCenter for Pharmaceutical Sciences and Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Xuanqin ChenCenter for Pharmaceutical Sciences and Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Dan LiuCenter for Pharmaceutical Sciences and Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Rongtao LiCenter for Pharmaceutical Sciences and Engineering, Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Kunming University of Science and Technology · CN

Funding

Higher Educational Key Laboratory for New drugs for Viral Respiratory Diseases (Chinese Tra-ditional Medicine) of Yunnan Province, and the Key Project of Research and Development of Yunnan Province 202103AC10005Innovative Team of Yunnan Province 2019HC018National Natural Science Foundation of China 22067012National Natural Science Foundation of China 82060737National Natural Science Foundation of China 82073737Science and Technology Planning Project of Yunnan Province 202001AT070122
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EuphorbiaApoptosisCell ProliferationHep G2 CellsHumansMacrophagesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-aktantitumordual antitumor activityEuphorbia kansuiimmunomodulatoryNa+, K+-ATPaseα1 subunit of NAK

Identifiers

PMID36985801
PMCPMC10058894
OpenAlexW4353073789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.